Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome.

OBJECTIVE To present a complementary hypothesis concerning the pathogenesis of the multiple organ dysfunction syndrome. DATA SOURCES Primary reports and reviews published in peer-reviewed medical and scientific journals. HYPOTHESIS We suggest that healthy organs behave as biological oscillators, which couple to one another during human development, and that this orderly coupling is maintained through a communications network, including neural, humoral, and cytokine components. We suggest that the systemic inflammatory response syndrome initiates disruption of communication and uncoupling, and further suggest that progression into the multiple organ dysfunction syndrome reflects progressive uncoupling that can become irreversible. Resolution of the inflammatory response and reestablishment of the communications network are necessary but may not be, by itself, sufficient to allow organs to appropriately recouple. This hypothesis is testable using existing laboratory and clinical tools.

[1]  R J Cohen,et al.  Power spectrum analysis of heart rate variability in human cardiac transplant recipients. , 1989, Circulation.

[2]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[3]  Steven M. Pincus,et al.  Approximate Entropy of Heart Rate as a Correlate of Postoperative Ventricular Dysfunction , 1993, Anesthesiology.

[4]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[5]  G. Koch,et al.  Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome: A Randomized, Controlled, Double-blind, Multicenter Clinical Trial , 1995 .

[6]  F. Cerra,et al.  Selective gut decontamination reduces nosocomial infections and length of stay but not mortality or organ failure in surgical intensive care unit patients. , 1992, Archives of surgery.

[7]  A. Baue.  The horror autotoxicus and multiple-organ failure. , 1992, Archives of surgery.

[8]  J. Fierer,et al.  Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. , 1982, The New England journal of medicine.

[9]  D. T. Kaplan,et al.  Aging and the complexity of cardiovascular dynamics. , 1991, Biophysical journal.

[10]  S. Opal,et al.  Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. , 1994, JAMA.

[11]  A. Baue.  Multiple, progressive, or sequential systems failure. A syndrome of the 1970s. , 1975, Archives of surgery.

[12]  Martin Kacin,et al.  LOW‐FREQUENCY, PERIODIC FLUCTUATIONS IN PHYSIOLOGIC VARIABLES OF CRITICALLY ILL PATIENTS , 1995 .

[13]  W. Ditto,et al.  Taming spatiotemporal chaos with disorder , 1995, Nature.

[14]  S. Nasraway,et al.  Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. , 1995, JAMA.

[15]  R. L. Fulton,et al.  Multiple system organ failure. The role of uncontrolled infection. , 1980, Archives of surgery.

[16]  S M Pincus,et al.  Approximate entropy as a measure of system complexity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Bailey,et al.  Sequential System Failure after Rupture of Abdominal Aortic Aneurysms: An Unsolved Problem in Postoperative Care , 1973, Annals of surgery.

[18]  J. Nerup,et al.  Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury. , 1995, Critical care medicine.

[19]  W G Baxt,et al.  Complexity, chaos and human physiology: the justification for non-linear neural computational analysis. , 1994, Cancer letters.

[20]  J. Marshall,et al.  The microbiology of multiple organ failure. The proximal gastrointestinal tract as an occult reservoir of pathogens. , 1988, Archives of surgery.

[21]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[22]  Fry De,et al.  Patterns of morbidity and mortality in splenic trauma. , 1980 .

[23]  D. Remick,et al.  Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. , 1992, The Journal of clinical investigation.

[24]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[25]  S. Lemeshow,et al.  Modeling the severity of illness of ICU patients. A systems update. , 1994, JAMA.

[26]  D. Hoyt,et al.  Spectral analysis of heart rate variability in the ICU: a measure of autonomic function. , 1996, The Journal of surgical research.

[27]  T. Buchman,et al.  A comparison of statistical and connectionist models for the prediction of chronicity in a surgical intensive care unit , 1994, Critical care medicine.

[28]  M. H. Kempski,et al.  Autonomic modulation of heart rate variability during endotoxin shock in rabbits. , 1995, Critical care medicine.

[29]  D. Alling,et al.  A controlled trial of HA-1A in a canine model of gram-negative septic shock. , 1993, JAMA.

[30]  R. Danner,et al.  Endotoxemia in human septic shock. , 1991, Chest.

[31]  T G Buchman,et al.  Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial. , 1996, Critical care medicine.

[32]  J. Dhainaut,et al.  CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group. , 1995, Critical care medicine.

[33]  Gérard Weisbuch,et al.  Phase transition in cellular random Boolean nets , 1987 .

[34]  C. Dinarello,et al.  A specific receptor antagonist for interleukin 1 prevents Escherichia coli‐induced shock in rabbits , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  T. Ikejima,et al.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. , 1988, The Journal of clinical investigation.

[36]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[37]  Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. , 1995 .

[38]  S. Banks,et al.  Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. , 1995, Journal of immunology.

[39]  Adam Seiver,et al.  FOURTH ORDER BLOOD PRESSURE WAVES SEEN USING AN INTERACTIVE COMPUTER SYSTEM , 1993 .

[40]  J. E. Skinner,et al.  Chaos and physiology: deterministic chaos in excitable cell assemblies. , 1994, Physiological reviews.

[41]  G. Grau,et al.  Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies , 1990, The Journal of experimental medicine.

[42]  J. Vincent,et al.  Influence of an anti‐tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis , 1993, Critical care medicine.

[43]  R. Seibel,et al.  Multiple systems organ failure: muscle fuel deficit with visceral protein malnutrition. , 1976, The Surgical clinics of North America.

[44]  L. Norton.  Does drainage of intraabdominal pus reverse multiple organ failure? , 1985, American journal of surgery.

[45]  E. Deitch.  Tumor necrosis factor as the proximal mediator of sepsis--or this too will pass. , 1995, Critical care medicine.

[46]  M. Lamy,et al.  Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. , 1989, Critical care medicine.

[47]  D H Singer,et al.  Low heart rate variability and sudden cardiac death. , 1988, Journal of electrocardiology.

[48]  C. Sprung,et al.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. , 1991 .

[49]  Craig R. Smith,et al.  Treatment of Septic Shock with Human Monoclonal Antibody HA-1A , 1994, Annals of Internal Medicine.

[50]  R. F. Johnston,et al.  Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial , 1994 .

[51]  W. Stevenson,et al.  Patterns of beat-to-beat heart rate variability in advanced heart failure. , 1992, American heart journal.

[52]  S. Trottier,et al.  Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trial. , 1995, Critical care medicine.

[53]  S M Pincus,et al.  Greater signal regularity may indicate increased system isolation. , 1994, Mathematical biosciences.

[54]  B. Beutler,et al.  Identity of tumour necrosis factor and the macrophage-secreted factor cachectin , 1985, Nature.

[55]  S. Kauffman,et al.  Coevolution to the edge of chaos: coupled fitness landscapes, poised states, and coevolutionary avalanches. , 1991, Journal of theoretical biology.

[56]  Robert M. May,et al.  Simple mathematical models with very complicated dynamics , 1976, Nature.